Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 1.00 |
| ▸ | PPARD | Q03181 | 1/20 | 1.00 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 1.00 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 1.00 |
| ▸ | ZDHHC7 | Q9NXF8 | 2/20 | 0.62 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.48 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9096771 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL817063 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL3790420 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL375050 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL338250 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL338237 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL23829555 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL10595854 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL337479 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 | |
| SCHEMBL2721068 | 1.00 | LCK (1.00) | LCKPPARDZDHHC20ZDHHC2ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 777 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637728-A1 | COMPOSITION | BioNTech Delivery Technologies GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| CN-119345174-A | Application of 2-bromopalmitic nose drops in preparation of antidepressant drugs | 华中科技大学 | 2025-01-24 | — | — | CN | claimed |
| WO-2024207142-A1 | USE OF COMPOUND 2-BROMOPALMITATE IN TREATMENT OF CEREBROVASCULAR DISEASES | 苏州大学 | 2024-10-10 | — | — | WO | claimed |
| CN-118267383-A | Application of 2-bromohexadecanoic acid in preparation of tumor drug resistance reversal preparation | 天津市肿瘤医院（天津医科大学肿瘤医院） | 2024-07-02 | — | — | CN | claimed |
| CN-117987127-A | Application of oil displacement agent containing nano carboxyl lignin derivative dispersion liquid in oil and gas exploitation | 辽宁石油化工大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117159529-A | Palmitoylation inhibitor and application of palmitoylase ZDHHC24 inhibitor in liver cancer | 中山大学附属第一医院 | 2023-12-05 | — | — | CN | claimed |
| CN-115317473-B | Use of palmitoylation inhibitor in preparation of peripheral blood hematopoietic stem/progenitor cell mobilizing medicine | 中国人民解放军军事科学院军事医学研究院 | 2023-10-13 | — | — | CN | claimed |
| US-20230293521-A1 | METHODS FOR SCREENING NOVEL CORONAVIRUS ANTIVIRALS AND METHODS OF USING ANTIVIRALS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-09-21 | — | — | US | claimed |
| CN-114306306-B | Application of 2-bromopalmitic acid in preparation of medicine for treating diseases related to spermatogenic dysfunction | 中国人民解放军东部战区总医院 | 2023-08-22 | — | — | CN | claimed |
| CN-116492461-A | Palmitoylation inhibitors and PARP inhibitors for use in the treatment of tumors | 大连医科大学附属第二医院 | 2023-07-28 | — | — | CN | claimed |
| US-6395796-B1 | CONDENSATION OF POLYISOCYANATE AND POLYOL USING DELAYED ACTION AMINE CATALYST FORMED BY REACTION OF HALOCARBOXYLIC ACID AND TERTIARY AMINE | CROMPTON CORPORATION | 2002-05-28 | — | — | US | claimed |
| US-6387972-B1 | MIXTURE CONTAINING TERTIARY AMINE ADJUVANT | CROMPTON CORPORATION | 2002-05-14 | — | — | US | claimed |
| WO-2001021173-A1 | NOVEL USES OF 2-BROMOPALMITATE | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2001-03-29 | — | — | WO | claimed |
| CN-1269372-A | Process for producing polyurethane foam plastics | CK THE WHITAKER CORP (US) | 2000-10-11 | — | — | CN | claimed |
| EP-1018525-A1 | Process for preparing polyurethane foam | CK WITCO CORPORATION (US) | 2000-07-12 | — | — | EP | claimed |
| US-5866607-A | 2-HYDROXY- OR 2-BROMO-FATTY ACIDS | BTG INTERNATIONAL LIMITED (GB) | 1999-02-02 | — | — | US | claimed |
| US-5759734-A | Method of generating simulated photographic-quality images on luminescent melt-formed backing substrates | XEROX CORPORATION (US) | 1998-06-02 | — | — | US | claimed |
| US-5714516-A | ADMINISTERING 2-HYDROXYMYRISTIC ACID OR PENTADECANOIC OR HEXADECANOIC ACIDS 2-SUBSTITUTED WITH HYDROXY OR BROMINE AS NONTOXIC AGENT AGAINST HERPES VIRUS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1998-02-03 | — | — | US | claimed |
| EP-0644758-A1 | USE OF FATTY ACIDS, E.G. Z-HYDROXYMYSTIC ACIDS, AS ANTIVIRAL AGENTS | BTG INTERNATIONAL LIMITED (GB) | 1995-03-29 | — | — | EP | claimed |
| WO-1993025200-A1 | USE OF FATTY ACIDS, E.G. Z-HYDROXYMYSTIC ACIDS, AS ANTIVIRAL AGENTS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1993-12-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293521-A1 | METHODS FOR SCREENING NOVEL CORONAVIRUS ANTIVIRALS AND METHODS OF USING ANTIVIRALS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS | SARS1, ACE, ACE2 | LCK 3477/4885PPARD 3351/4885ZDHHC20 543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.